Eli Goldberger
Chairman chez EOM PHARMACEUTICALS HOLDINGS, INC.
Profil
Eli Goldberger is the founder of Payday Solutions (founded in 2007), EOM Pharmaceuticals, Inc. (founded in 2020), and Prepogen LLC (founded in 2016).
He held the title of President at Payday Solutions from 2007 to 2015, Chairman & Chief Operating Officer at EOM Pharmaceuticals, Inc. from 2020 to present, and Chief Executive Officer at Prepogen LLC from 2017 to present.
Mr. Goldberger is also the founder of ImmunoCellular Therapeutics Ltd.
Currently, Mr. Goldberger holds the position of Chairman & Chief Operating Officer at EOM Pharmaceuticals Holdings, Inc., Director at Universal Energy Corp., and President at PDJ Components, Inc.
Postes actifs de Eli Goldberger
| Sociétés | Poste | Début |
|---|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Chairman | 27/03/2020 |
| UNIVERSAL ENERGY CORP. | Director/Board Member | - |
EOM Pharmaceuticals, Inc.
 EOM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of EOM Pharmaceuticals Holdings, Inc., EOM Pharmaceuticals, Inc. is a privately held, clinical-stage company focused on developing novel drugs to improve the quality of life for patients with debilitating and sometimes deadly diseases. The company is based in Montvale, NJ. The company's mission is to pursue innovative approaches with small molecule therapeutics to address urgent and unmet medical needs. EOM's pipeline includes the development of the first-and-only dual-acting, broad-spectrum immunomodulator EOM613, which has the potential to treat systemic illnesses caused by intense inflammatory immune reactions, including COVID-19, influenza, and cancer cachexia. Additionally, EOM is working on an advanced formulation of EOM147, the first potential topically administered eye drop for treating retinal diseases. The company was founded by Shalom Z. Hirschman and Eli Goldberger, and Irach B. Taraporewala has been the CEO since 2020. EOM Pharmaceuticals was acquired by ImmunoCellular Therapeutics Ltd. on December 02, 2021. | Founder | 01/03/2020 |
| Prepogen LLC | Chief Executive Officer | 01/01/2017 |
PDJ Components, Inc.
 PDJ Components, Inc. Forest ProductsNon-Energy Minerals PDJ Components, Inc. is a private company based in Chester, NY that specializes in building wall panels, floor and roof trusses. The company's manufacturing plant is centrally located within 60 miles of NYC with access to 3 major interstate highways. The company is one of four truss plate institute inspected plants in the state and supply local lumberyards in NY, NJ, PA, and the mid-states. PDJ Components is equipped to handle both large ongoing projects and one-time small garage or residence projects. Engineered seals arrive at the job site upon delivery of trusses. | President | 01/01/2017 |
Anciens postes connus de Eli Goldberger
| Sociétés | Poste | Fin |
|---|---|---|
Payday Solutions
 Payday Solutions Miscellaneous Commercial ServicesCommercial Services Part of The Sage Group plc, Payday Solutions is a private company that provides accounting services. The company is based in Louisville, KY. The company was founded by Eli Goldberger. | Founder | 01/07/2015 |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Founder | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| UNIVERSAL ENERGY CORP. | Producer Manufacturing |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Payday Solutions
Payday Solutions Miscellaneous Commercial ServicesCommercial Services Part of The Sage Group plc, Payday Solutions is a private company that provides accounting services. The company is based in Louisville, KY. The company was founded by Eli Goldberger. | Commercial Services |
PDJ Components, Inc.
PDJ Components, Inc. Forest ProductsNon-Energy Minerals PDJ Components, Inc. is a private company based in Chester, NY that specializes in building wall panels, floor and roof trusses. The company's manufacturing plant is centrally located within 60 miles of NYC with access to 3 major interstate highways. The company is one of four truss plate institute inspected plants in the state and supply local lumberyards in NY, NJ, PA, and the mid-states. PDJ Components is equipped to handle both large ongoing projects and one-time small garage or residence projects. Engineered seals arrive at the job site upon delivery of trusses. | Non-Energy Minerals |
EOM Pharmaceuticals, Inc.
EOM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of EOM Pharmaceuticals Holdings, Inc., EOM Pharmaceuticals, Inc. is a privately held, clinical-stage company focused on developing novel drugs to improve the quality of life for patients with debilitating and sometimes deadly diseases. The company is based in Montvale, NJ. The company's mission is to pursue innovative approaches with small molecule therapeutics to address urgent and unmet medical needs. EOM's pipeline includes the development of the first-and-only dual-acting, broad-spectrum immunomodulator EOM613, which has the potential to treat systemic illnesses caused by intense inflammatory immune reactions, including COVID-19, influenza, and cancer cachexia. Additionally, EOM is working on an advanced formulation of EOM147, the first potential topically administered eye drop for treating retinal diseases. The company was founded by Shalom Z. Hirschman and Eli Goldberger, and Irach B. Taraporewala has been the CEO since 2020. EOM Pharmaceuticals was acquired by ImmunoCellular Therapeutics Ltd. on December 02, 2021. | Health Technology |
| Prepogen LLC |
